MAP3K7 and metabolic dysfunction-associated steatotic liver disease: More interestingly, a recent study reported that RGS5 is an essential regulator protecting against the progression of NAFLD by preventing its hyperphosphorylation of TAK1 and the activation of the downstream JNK/p38 signaling cascade [11].